Genopathy
Gene-Disorder Association · Article
Gene
CDKN2A
Cyclin Dependent Kinase Inhibitor 2A
Disorder
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
First reported 2017
Supporting publications 1
Key publication · disorder B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.Oncotarget · 2017
Manually curated
Association Review

In brief

The association between CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) and B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2) is a manually-curated gene–disease association, supported by a single expert-curated source.

Sources 1
Clinical variants 0
Symptoms 0
Compounds 0
Trials 0
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CDKN2A

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)

The disorder

5 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access